Abra Information Technologies (TASE:ABRA) Margin Compression Challenges Bullish Growth Narrative

Advertisement

FY 2025 earnings snapshot

Abra Information Technologies (TASE:ABRA) has just wrapped up FY 2025 with fourth quarter revenue of ₪161.8m and basic EPS of ₪0.041657, supported by trailing twelve month revenue of ₪554.0m and EPS of ₪0.12 as investors weigh what these numbers say about the business at a share price of ₪3.914. The company has seen quarterly revenue move from ₪116.6m in Q4 2024 to ₪161.8m in Q4 2025, while basic EPS shifted from ₪0.03811 to ₪0.041657 over the same period. This gives a clearer view of how the top line and per share profits are tracking year on year. With net margin at 2.4% for the last year versus 3.1% previously, the story this season is less about headline growth and more about how efficiently that revenue is being turned into profit.

See our full analysis for Abra Information Technologies.

With the numbers on the table, the next step is to set them against the most common stories around Abra Information Technologies to see which narratives hold up and which ones the latest margin profile starts to challenge.

Curious how numbers become stories that shape markets? Explore Community Narratives

TASE:ABRA Revenue & Expenses Breakdown as at Mar 2026
TASE:ABRA Revenue & Expenses Breakdown as at Mar 2026

11.9% revenue growth outlook meets softer 2.4% margin

  • Trailing twelve month revenue sits at ₪554.0m with net income of ₪13.5m, which works out to a 2.4% net margin compared with 3.1% the prior year, alongside a forecast revenue growth rate of about 11.9% per year.
  • Bulls highlight ABRA’s 37.9% annualised earnings growth over the past five years and the forecast 11.9% revenue growth. However, the latest 2.4% net margin versus 3.1% a year earlier creates a tension between the long run profit story and the most recent margin compression.
    • That 37.9% multi year earnings growth figure lines up with trailing twelve month net income of ₪13.5m, but the margin step down shows that recent profit quality is not moving in the same direction as the longer run trend.
    • Supporters of the bullish view can point to the higher trailing twelve month revenue base of ₪554.0m as the platform for future growth, while critics will focus on whether a 2.4% margin leaves enough room for earnings to keep pace with the earlier 37.9% trajectory.

P/E of 33.8x versus industry 22x

  • ABRA trades on a trailing P/E of 33.8x at a share price of ₪3.914, compared with 22x for the broader Asian Software industry and 32x for peers, while a DCF fair value of ₪5.45 sits above the current market level.
  • Bears argue that paying 33.8x earnings for a business with a 2.4% net margin is demanding. Yet the supplied DCF fair value of ₪5.45 versus the current price of ₪3.91, around 28% higher, means the valuation picture is not one sided.
    • The 33.8x P/E premium to the 22x industry average backs the bearish concern that expectations embedded in the multiple are higher than for many software names, despite ABRA’s thinner trailing margin.
    • At the same time, the DCF fair value gap of roughly ₪1.54 per share indicates that, if the cash flow assumptions prove realistic, the current price is below that model’s estimate, which challenges a purely bearish take that the stock is simply expensive.

Quarterly earnings climb from ₪2.8m to ₪4.2m

  • Within FY 2025, net income excluding extra items moved from ₪2.8m in Q1 2025 to ₪4.2m in Q4 2025, with basic EPS over those quarters moving from ₪0.02 to ₪0.041657 as revenue ranged between ₪119.4m and ₪161.8m.
  • What stands out against a cautious view that focuses on the dip in annual net margin is that, inside the year, reported net income moved higher from ₪2.8m to ₪4.2m. This suggests the most recent quarter ended with a higher profit level even as the full year margin settled at 2.4%.
    • Critics highlight the margin difference between the latest 2.4% and the prior 3.1%, but the Q4 2025 net income of ₪4.2m is in line with Q4 2024’s ₪4.2m while being earned on a higher revenue base of ₪161.8m versus ₪116.6m.
    • For readers comparing this to the 37.9% annualised five year earnings growth, the quarterly pattern within 2025 shows that profits have held in the ₪3.0m to ₪4.2m range as revenue scaled up, which gives more detail behind the headline margin compression story.

For a fuller picture of how other investors are interpreting these moving parts around growth, margins, and valuation, it is worth seeing how the broader community frames Abra Information Technologies’ story through Curious how numbers become stories that shape markets? Explore Community Narratives

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Abra Information Technologies's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

With the mix of positives and concerns in mind, readers who move quickly can weigh the same data and reach their own view using the 2 key rewards and 1 important warning sign.

See What Else Is Out There

Abra Information Technologies pairs a 33.8x P/E and a 2.4% net margin with compressed profitability relative to the prior 3.1%, which raises value concerns.

If you are questioning whether that combination really stacks up at the current price, it is worth lining it up against companies in the 232 high quality undervalued stocks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About TASE:ABRA

Abra Information Technologies

Provides information technology solutions in Israel.

Excellent balance sheet with acceptable track record.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1157.5% undervalued
47 users have followed this narrative
2 users have commented on this narrative
7 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7721.4% undervalued
67 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$19013.7% undervalued
24 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative

Updated Narratives

WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.8% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
CHTR logo
david_6nroa on Charter Communications ·

Charter is undervalued - Here's why.

Fair Value:US$87.0741.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.919.1% undervalued
81 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28026.1% undervalued
185 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.6% undervalued
71 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0